Your browser doesn't support javascript.
loading
Heterogeneous tumor-immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti-PD-L1 antibody therapy.
Sakata, Shinya; Imamura, Kosuke; Tajima, Yuka; Masuda, Yuiko; Sato, Ryo; Yoshida, Chieko; Okamoto, Shinichiro; Saeki, Sho; Tomita, Yusuke; Sakagami, Takuro.
Afiliación
  • Sakata S; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Imamura K; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Tajima Y; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Masuda Y; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Sato R; Laboratory of Stem Cell and Neuro-Vascular Biology, Genetics and Developmental Biology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • Yoshida C; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Okamoto S; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Saeki S; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Tomita Y; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Sakagami T; Department of Respiratory Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Thorac Cancer ; 12(3): 397-401, 2021 02.
Article en En | MEDLINE | ID: mdl-33300302

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tumor Carcinoide / Inhibidores de Puntos de Control Inmunológico Límite: Aged / Humans / Male Idioma: En Revista: Thorac Cancer Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Singapur

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tumor Carcinoide / Inhibidores de Puntos de Control Inmunológico Límite: Aged / Humans / Male Idioma: En Revista: Thorac Cancer Año: 2021 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Singapur